Skip to main content

Main menu

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Information for authors
  • About the journal
    • About the journal
    • Editorial board
    • Information for authors
    • FAQs
    • Thank you to our reviewers
      • Thank you to our reviewers
    • American Federation for Medical Research
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
  • BMJ Journals

User menu

  • Login

Search

  • Advanced search
  • BMJ Journals
  • Login
  • Facebook
  • Twitter
JIM

Advanced Search

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Information for authors
  • About the journal
    • About the journal
    • Editorial board
    • Information for authors
    • FAQs
    • Thank you to our reviewers
    • American Federation for Medical Research
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising

Saying goodbye and remembering

Richard W McCallum
DOI: 10.1136/jim-2022-123123 Published 1 December 2022
Richard W McCallum
1 Center for Neurogastroenterology and GI Motility Gastroenterology/Hepatology and Nutrition, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, Texas, USA
2 University of Queensland, Brisbane, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Well, colleagues, this will be my last Editorial for the Journal of Investigative Medicine (JIM) under the BMJ flag. Beginning in January 2023, JIM will publish under the aegis of a new publisher, SAGE.

For me, the last 3 years as Editor-in-Chief of JIM have been both very exciting and rewarding, and I will briefly summarize some of the highlights and achievements from my tenure.

  • 2019: I was appointed EIC mid-year, and per my first editorial,1 one of my key strategies was to introduce new article types that addressed faculty development, education, mentoring, and careers.

  • 2020: In addition to celebrating JIM’s 25th anniversary, we introduced a monthly podcast. The first episode featured my personal perspectives on the microbiome field. Since that time, we’ve published 33 podcasts, with an average of 444 listens per podcast.

  • 2021: Submission growth surpassed previous years, showing an increase of 50% from 2016 to 2021. On the heels of the COVID-19 pandemic, JIM published two articles that have generated a great deal of attention, as evidenced by their Altmetrics scores: ‘Long COVID-19 following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines’,2 a research article published in October by Glynne et al, and ‘COVID-19 reinfection: a rapid systematic review of case reports and case series’,3 a brief report published in May by Wang et al. The first of these articles is the highest downloaded article published since JIM began at BMJ.

  • 2022: At this writing, the editorial team continues to improve the quality of JIM submissions, as evidenced by an immediate rejection rate of nearly 50% and a decreased acceptance rate for all papers of 28%. Web traffic has grown steadily in the past 5 years and is expected to increase by 20% over 2021, and JIM’s 2021 impact factor of 3.301 (announced in June 2022) was a 14% increase over 2020, evidence of the improved quality of the content published in JIM.

I want to take this opportunity to sincerely thank the BMJ team for their ‘stewardship’ of JIM. Specifically, I am deeply grateful to Kathleen Lyons, head of Portfolio, based in Hoboken, New Jersey (yes, the birthplace of Frank Sinatra); Hannah Martin, based in London, JIM’s production editor, who helped us produce and finalize each issue from BMJ; and our great editorial assistant team of Rachel Wright, Chloe Tuck, and Caty Waterfield.

Overall, I say to you, my American Federation for Medical Research (AFMR) colleagues and all our readers and contributors to JIM, in the words of an Australian with a love for cricket, we have had a good ‘inning’ with BMJ and will always be grateful and appreciative of the ties and relationship between AFMR and BMJ.

Ethics statements

Patient consent for publication

Not applicable.

Footnotes

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

References

  1. ↵
    1. McCallum RW
    . Richard W. McCallum, MD: New Editor-in-Chief, Journal of Investigative Medicine. J Investig Med 2020;68:1–2.doi:10.1136/jim-2019-001234 pmid:http://www.ncbi.nlm.nih.gov/pubmed/31857438
    OpenUrlFREE Full Text
  2. ↵
    1. Glynne P ,
    2. Tahmasebi N ,
    3. Gant V , et al
    . Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Investig Med 2022;70:61–7.doi:10.1136/jim-2021-002051 pmid:http://www.ncbi.nlm.nih.gov/pubmed/34611034
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Wang J ,
    2. Kaperak C ,
    3. Sato T , et al
    . COVID-19 reinfection: a rapid systematic review of case reports and case series. J Investig Med 2021;69:1253–5.doi:10.1136/jim-2021-001853 pmid:http://www.ncbi.nlm.nih.gov/pubmed/34006572
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Vol 70 Issue 8 Table of Contents
Journal of Investigative Medicine: 70 (8)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Front Matter (PDF)
Email

Thank you for your interest in spreading the word on JIM.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Saying goodbye and remembering
(Your Name) has sent you a message from JIM
(Your Name) thought you would like to see the JIM web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Saying goodbye and remembering
Richard W McCallum
Journal of Investigative Medicine Dec 2022, 70 (8) 1661; DOI: 10.1136/jim-2022-123123

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Cite This
  • APA
  • Chicago
  • Endnote
  • MLA
Loading
Saying goodbye and remembering
Richard W McCallum
Journal of Investigative Medicine Dec 2022, 70 (8) 1661; DOI: 10.1136/jim-2022-123123
Download PDF

Share
Saying goodbye and remembering
Richard W McCallum
Journal of Investigative Medicine Dec 2022, 70 (8) 1661; DOI: 10.1136/jim-2022-123123
Reddit logo Twitter logo Facebook logo Mendeley logo
Respond to this article
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Article
    • Ethics statements
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • COVID-19 vaccine efficacy in a rapidly changing landscape
  • New agents for sickle cell disease: patient perceptions of benefit in the real world
Show more Editorial

Similar Articles

 

CONTENT

  • Latest content
  • Current issue
  • Archive
  • Sign up for email alerts
  • RSS

JOURNAL

  • About the journal
  • Editorial board
  • Subscribe
  • Thank you to our reviewers
  • American Federation for Medical Research

AUTHORS

  • Information for authors
  • Submit a paper
  • Track your article
  • Open Access at BMJ

HELP

  • Contact us
  • Reprints
  • Permissions
  • Advertising
  • Feedback form

© 2023 American Federation for Medical Research